Contineum Insider Sale Signals Routine Liquidity, Not DistressInsider sale by Contineum’s CSO shows routine liquidity planning amid rising stock—no distress sign, but watch future filings for shifts.Contineum Therapeutics Inc Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 05/02/2026, 22:41 3 minutes to read
